MARKET

SLS

SLS

SELLAS LIFE SCIE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.70
-0.02
-0.26%
Closed 19:34 05/05 EDT
OPEN
7.78
PREV CLOSE
7.72
HIGH
7.90
LOW
7.52
VOLUME
89.01K
TURNOVER
--
52 WEEK HIGH
19.38
52 WEEK LOW
1.760
MARKET CAP
116.15M
P/E (TTM)
-3.4842
1D
5D
1M
3M
1Y
5Y
Industrial Burner Market 2021 : Latest Industry Size, Growth, Share, Demand, Trends, Competitive Landscape and Forecasts to 2025 with Top Countries Data
May 05, 2021 (The Expresswire) -- According to 360 Research Reports, the “Industrial Burner Market" 2021 by Types (Oil-based, Gas-based, Dual fuel),...
The Express Wire · 1d ago
Gas Burners Market 2021-2027: Latest Covid-19 Impact Analysis, Size, Share, Growth, Opportunity and Forecasts
May 05, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The global “Gas Burners Market” is...
The Express Wire · 1d ago
Industrial Gas Burner Market Trends 2021| Segmentation, Outlook, Industry Report with Forecast till 2027
May 05, 2021 (The Expresswire) -- The “Industrial Gas Burner Market” Research Report is framed after handling an in-depth study of the Industrial Gas Burner...
The Express Wire · 1d ago
Industrial Burner Market Shows Surprisingly Growth in Coming Years
The Express Wire · 04/27 14:11
Industrial Burners Market Size 2021 Analysis including Comparison by Regions Status, Prospect, Manufacturers Profiles and Forecast to 2024
Apr 26, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." An Industrial burner is a mechanical...
The Express Wire · 04/26 12:15
CORRECTION: Biotechs Working on Potential Preventive Measures and Cancer Treatments
PR Newswire Europe · 04/22 14:31
Industrial Coal Burner Market Research Study including Growth Factors, Types and Application by regions from 2021 to 2027
Apr 22, 2021 (The Expresswire) -- global “Industrial Coal Burner Market” Report deliver comprehensive analysis of the market structure along with forecast of...
The Express Wire · 04/22 12:11
Global Industrial Burners Market Growth 2021, Trend Analysis, Area Marketplace Expanding, Technological Innovations, Business Strategic, Forecast To 2025
Apr 22, 2021 (The Expresswire) -- Global "Industrial Burners Market" (2021) examines the effect of different Factors affecting the market development and...
The Express Wire · 04/22 07:50
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SLS. Analyze the recent business situations of SELLAS LIFE SCIE through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SLS stock price target is 10.00 with a high estimate of 12.00 and a low estimate of 8.00.
EPS
Institutional Holdings
Institutions: 42
Institutional Holdings: 9.74M
% Owned: 64.54%
Shares Outstanding: 15.08M
TypeInstitutionsShares
Increased
4
476.91K
New
9
84.14K
Decreased
2
27.68K
Sold Out
2
225.12K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.92%
Pharmaceuticals & Medical Research
+0.20%
Key Executives
Chairman/Independent Director
Jane Wasman
President/Chief Executive Officer/Director
Angelos Stergiou
Executive Vice President/General Counsel/Secretary
Barbara Wood
Senior Vice President
Dragan Cicic
Chief Accounting Officer/Vice President - Finance/Controller
John Burns
Director
David Scheinberg
Independent Director
Robert Van Nostrand
Independent Director
Stephen Ghiglieri
Independent Director
John Varian
No Data
About SLS
SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company's NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase IIa clinical trial in ovarian and endometrial cancers and in a Phase Ib clinical trial given sequentially with GALE-302. The Company's therapies utilize an immunodominant peptide combined with the immune adjuvant, recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF, Leukine), and work by harnessing the patient's own immune system.

Webull offers kinds of Sellas Life Sciences Group Inc stock information, including NASDAQ:SLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SLS stock methods without spending real money on the virtual paper trading platform.